What does Dr. Eva De Caluwé, cardiologie do?

Dr. Eva De Caluwé, cardiologie is a specialist medical practice in Bierbeek. Private Limited, started on 21 December 2016, 1 establishment.

What is the address of Dr. Eva De Caluwé, cardiologie?

The registered office of Dr. Eva De Caluwé, cardiologie is located at Keibergstraat 10A, 3360 Bierbeek.

Is Dr. Eva De Caluwé, cardiologie still active?

Yes. According to the CBE (15 September 2026) Dr. Eva De Caluwé, cardiologie is active, legal situation “Normale toestand”, started on 21 December 2016.

Is Dr. Eva De Caluwé, cardiologie registered on Peppol?

Yes, Dr. Eva De Caluwé, cardiologie is registered on the Peppol network with ID 0208:0667977236.

What is the enterprise number of Dr. Eva De Caluwé, cardiologie?

The enterprise number of Dr. Eva De Caluwé, cardiologie is BE0667977236.

When was Dr. Eva De Caluwé, cardiologie founded?

Dr. Eva De Caluwé, cardiologie was founded on 21 December 2016.

Who are the directors of Dr. Eva De Caluwé, cardiologie?

According to the 2025 annual accounts, the directors of Dr. Eva De Caluwé, cardiologie are: Eva De Caluwé .

Is Dr. Eva De Caluwé, cardiologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 December 2016; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Eva De Caluwé, cardiologie make in 2025?

Dr. Eva De Caluwé, cardiologie posted a profit after taxes of € 177,866 in financial year 2025.

What is the revenue of Dr. Eva De Caluwé, cardiologie?

As a small company, Dr. Eva De Caluwé, cardiologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 235,132.

Dr. Eva De Caluwé, cardiologie (Private Limited)

Dossier Dr. Eva De Caluwé, cardiologie, printed on 15 September 2026 from databakkes.be/en/0667977236/dr-eva-de-caluwe-cardiologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Eva De Caluwé, cardiologie from Bierbeek, company number BE0667977236, closed financial year 2025 with a result of € 177,866 after tax. For that financial year Dr. Eva De Caluwé, cardiologie recorded a gross margin of € 235,132 and equity of € 18,600. Compared with financial year 2024, the result moved from € 187,054 to € 177,866. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 9, 2026.

What it is worth Healthy

€ 18,600

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 177,866

▼ 5% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 122,268

▼ 1% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 177,866 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 8,729

▼ 29% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,954

▲ 41% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 122,491 Gross margin 2022: € 122,491 First fiscal year in the series	€ 213,852 Gross margin 2023: € 213,852 ▲ 75% vs 2022 (€ 122,491) Favourable step	€ 247,573 Gross margin 2024: € 247,573 ▲ 16% vs 2023 (€ 213,852) Favourable step	€ 235,132 Gross margin 2025: € 235,132 ▼ 5% vs 2024 (€ 247,573) Unfavourable step	▼ 5%
Profit after taxes	€ 92,396 Profit after taxes 2022: € 92,396 First fiscal year in the series	€ 161,400 Profit after taxes 2023: € 161,400 ▲ 75% vs 2022 (€ 92,396) Favourable step	€ 187,054 Profit after taxes 2024: € 187,054 ▲ 16% vs 2023 (€ 161,400) Favourable step	€ 177,866 Profit after taxes 2025: € 177,866 ▼ 5% vs 2024 (€ 187,054) Unfavourable step	▼ 5%
Equity	€ 20,460 Equity 2022: € 20,460 First fiscal year in the series	€ 20,460 Equity 2023: € 20,460 Unchanged (€ 20,460) Unchanged	€ 18,600 Equity 2024: € 18,600 ▼ 9% vs 2023 (€ 20,460) Unfavourable step	€ 18,600 Equity 2025: € 18,600 Unchanged (€ 18,600) Unchanged
Total debts	€ 92,475 Total debts 2022: € 92,475 First fiscal year in the series	€ 165,860 Total debts 2023: € 165,860 ▲ 79% vs 2022 (€ 92,475) Unfavourable step	€ 192,434 Total debts 2024: € 192,434 ▲ 16% vs 2023 (€ 165,860) Unfavourable step	€ 182,825 Total debts 2025: € 182,825 ▼ 5% vs 2024 (€ 192,434) Favourable step	▼ 5%
Cash	€ 68,125 Cash 2022: € 68,125 First fiscal year in the series	€ 113,581 Cash 2023: € 113,581 ▲ 67% vs 2022 (€ 68,125) Favourable step	€ 123,312 Cash 2024: € 123,312 ▲ 9% vs 2023 (€ 113,581) Favourable step	€ 122,268 Cash 2025: € 122,268 ▼ 1% vs 2024 (€ 123,312) Unfavourable step	▼ 1%
Retained profit	€ 1,860 Retained profit 2022: € 1,860 First fiscal year in the series	€ 1,860 Retained profit 2023: € 1,860 Unchanged (€ 1,860) Unchanged	€ 0 Retained profit 2024: € 0 ▼ 100% vs 2023 (€ 1,860) Unfavourable step	€ 0 Retained profit 2025: € 0 Unchanged (€ 0) Unchanged
Dividend	€ 92,396 Dividend 2022: € 92,396 First fiscal year in the series	€ 161,400 Dividend 2023: € 161,400 ▲ 75% vs 2022 (€ 92,396) Unchanged	€ 188,914 Dividend 2024: € 188,914 ▲ 17% vs 2023 (€ 161,400) Unchanged	€ 177,866 Dividend 2025: € 177,866 ▼ 6% vs 2024 (€ 188,914) Unchanged	▼ 6%
Balance sheet total	€ 112,935 Balance sheet total 2022: € 112,935 First fiscal year in the series	€ 186,320 Balance sheet total 2023: € 186,320 ▲ 65% vs 2022 (€ 112,935) Unchanged	€ 211,034 Balance sheet total 2024: € 211,034 ▲ 13% vs 2023 (€ 186,320) Unchanged	€ 201,425 Balance sheet total 2025: € 201,425 ▼ 5% vs 2024 (€ 211,034) Unchanged	▼ 5%

Key figures of Dr. Eva De Caluwé, cardiologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Eva De Caluwé, cardiologie?

What happened at Dr. Eva De Caluwé, cardiologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 9, 2026 New annual accounts for financial year 2025: profit of € 177,866 (▼ 5% vs 2024). Source: NBB ↗
Dec 21, 2016 New establishment in Bierbeek. KBO
Dec 21, 2016 Start of the company according to the CBE. KBO

In short

From € 92,396 profit in 2022 to € 177,866 profit in 2025.

Paid € 187,839 in corporate taxes since 2022.

Best year ever: 2024, with € 187,054 profit.

Paid out € 620,577 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Eva De Caluwé, cardiologie? We notify you, reason included.

Follow Dr. Eva De Caluwé, cardiologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Eva De Caluwé

Dr. Eva De Caluwé, cardiologie

Behind Dr. Eva De Caluwé, cardiologie is Eva De Caluwé .

See the full network in the app

Directors

According to the 2025 annual accounts

Eva De Caluwé

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Keibergstraat 10A

3360 Bierbeek

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0667.977.236

VAT number

BE 0667.977.236

Registered office

Keibergstraat 10A, 3360 Bierbeek

Names & denominations

Dr. Eva De Caluwé, cardiologie

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

21 December 2016

Peppol

Active · Active since 27 Dec 2025

Activities · NACE

Activiteiten van medisch specialisten

Verhuur en lease van medisch en paramedisch materieel

Activiteiten op het gebied van voeding

Overige menselijke gezondheidszorg, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗

Dr. Eva De Caluwé, cardiologie

Financials

What happened to Dr. Eva De Caluwé, cardiologie?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions